InvestorQ : Has the use of Remdesivir for COVID-19 been approved in India and what does that mean for Jubilant and Cipla?
Moii Chavate made post

Has the use of Remdesivir for COVID-19 been approved in India and what does that mean for Jubilant and Cipla?

Answer
user profile image
Sam Eswaran answered.
3 months ago


The Central Drugs Standard Control Organisation (CDSCO) has finally given the approval for the use of Remdesivir for treating COVID-19 patients but should only be administered to adults and children where the disease is severe. It may be recollected that Gilead Sciences Inc (the patent owner for Remdesivir) had approved manufacture of the drug by Indian companies like Jubilant Life, Cipla and Hetero Drugs under special emergency facilities. However, this approval will be for 5-days use and not for 10-days use as was originally requested. This approval was the key for companies to start manufacturing for domestic use and also for exports.